Your account is not claimed yet. You can sign up with ORCID to claim your account.

Young-Chul Kim (Young Chul Kim)

ORCID

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 20

Top Venues

Thoracic cancer

Journal of Korean medical science

Cells

PloS one

Chonnam National University Medical School

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chonnam National University Medical School Jan 1o 1995

South Korea

Professor :: Internal Medicine

Publications

Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Young-Ok Na, Hwa Kyung Park, Jae-Kyeong Lee, Bo-Gun Kho, Tae-Ok Kim, Hong Joon Shin, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Hyung-Joo Oh, Cheol-Kyu Park, In Jae Oh, Young-Chul Kim, Ha-Young Park
Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study. PloS one 17 (12) (2022)
Yunha Nam, Ho Cheol Kim, Young-Chul Kim, Seung Hun Jang, Kye Young Lee, Shin Yup Lee, Sang Hoon Lee, Sung Yong Lee, Seong Hoon Yoon, Jeong-Seon Ryu, Tae Won Jang, Yoon Soo Chang, Seung Joon Kim, Chan Kwon Park, Jeong Eun Lee, Chi Young Jung, Chang-Min Choi
Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting. Thoracic cancer 12 (6) (2021)
Tae-Ok Kim, Jae-Kyeong Lee, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Min-Seok Kim, Bo Gun Kho, Cheol-Kyu Park, In Jae Oh, Young-Chul Kim, Ha Young Park, Hong Joon Shin
Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness. PloS one 16 (2) (2021)
Su Yeon Lee, Young-Chul Kim, Kye Young Lee, Sung-Yong Lee, Shin Yup Lee, Min Ki Lee, Jeong Eun Lee, Seung Hun Jang, Tae-Won Jang, Chang-Min Choi
Multicenter real-world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non-small cell lung cancer. Thoracic cancer (2021)
Hayoung Choi, Jae-Kyeong Lee, Hyung-Joo Oh, Min-Seok Kim, Bo Gun Kho, Cheol-Kyu Park, In Jae Oh, Young-Chul Kim
Efficacy and dose of afatinib in patients with non-small cell lung cancer after failure of prior gefitinib or erlotinib treatment. Thoracic cancer 12 (10) (2021)
Cheol-Kyu Park, Sung-Yong Lee, Jae Cheol Lee, Chang-Min Choi, Shin Yup Lee, Tae-Won Jang, In Jae Oh, Young-Chul Kim
Phase II open-label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid-Lung-A. Thoracic cancer 12 (4) (2020)
Paul K Paik, Enriqueta Felip, Remi Veillon, Hiroshi Sakai, Alexis B Cortot, Marina C Garassino, Julien Mazieres, Santiago Viteri, Helene Senellart, Jan Van Meerbeeck, Jo Raskin, Niels Reinmuth, Pierfranco Conte, Dariusz Kowalski, Byoung Chul Cho, Jyoti D Patel, Leora Horn, Frank Griesinger, Ji-Youn Han, Young-Chul Kim, Gee-Chen Chang, Chen-Liang Tsai, James C-H Yang, Yuh-Min Chen, Egbert F Smit, Anthonie J van der Wekken, Terufumi Kato, Dilafruz Juraeva, Christopher Stroh, Rolf Bruns, Josef Straub, Andreas Johne, Jürgen Scheele, John V Heymach, Xiuning Le
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations. The New England journal of medicine 383 (10) (2020)
Da Hyun Kang, Cheol-Kyu Park, Chaeuk Chung, In Jae Oh, Young-Chul Kim, Dong Il Park, Jinhyun Kim, Gye Cheol Kwon, In Sun Kwon, Pureum Sun, Eui-Cheol Shin, Jeong Eun Lee
Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors. Immune network 20 (3) (2020)
Hyung-Joo Oh, Won Gi Jeong, Yongwhan Lim, Sang-Joon Koh, Sung Min Lee, Min-Seok Kim, Bo-Gun Koh, Tae-Ok Kim, Yoo-Duk Choi, In Jae Oh, Young-Chul Kim, Cheol-Kyu Park
Potentially fatal complications of systemic air embolism after computed tomography-guided transthoracic needle biopsy in lung cancer harboring epithelial growth factor receptor mutation: A case report. Thoracic cancer 11 (11) (2020)
Joon-Young Yoon, Cheol-Kyu Park, Yoo-Duk Choi, In Jae Oh, Young-Chul Kim
Predictive factors for long-term responders of pemetrexed maintenance treatment in non-small cell lung cancer. Thoracic cancer 10 (4) (2019)
Je-Seong Kim, Tai-Seung Nam, Jieun Kim, Bo-Gun Kho, Cheol-Kyu Park, In-Jae Oh, Young-Chul Kim
Myasthenia gravis and myopathy after nivolumab treatment for non-small cell lung carcinoma: A case report. Thoracic cancer 10 (10) (2019)
In Jae Oh, Cheol-Kyu Park, Young-Chul Kim
Superior vena cava syndrome with extensive collateral vessels. Thoracic cancer 10 (12) (2019)
Young Ju Jung, In Jae Oh, Youndong Kim, Jong Ha Jung, Minkyoung Seok, Woochang Lee, Cheol-Kyu Park, Jung-Hwan Lim, Young-Chul Kim, Woo Sung Kim, Chang-Min Choi
Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer. Journal of Korean medical science 33 (53) (2018)
Young-Chul Kim, Young Joo Won
The Development of the Korean Lung Cancer Registry (KALC-R). Tuberculosis and respiratory diseases 82 (2) (2018)
Cheol-Kyu Park, Jae Young Hur, Chang-Min Choi, Tae Ok Kim, Hyun Ju Cho, Hong Joon Shin, Jung-Hwan Lim, Yoo Duk Choi, Young-Chul Kim, In Jae Oh
Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report. Journal of Korean medical science 33 (1) (2018)
Cheol-Kyu Park, Hyun Wook Kang, In Jae Oh, Young-Chul Kim, Yeo Kyeoung Kim, Kook Joo Na, Sung Ja Ahn, Tae Ok Kim, Young Jin Choi, Geun Am Song, Min Ki Lee
Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study. Journal of Korean medical science 31 (12) (2017)
Bo-Ram Lee, Yu-Il Kim, Sun Min Kim, Ho-Sung Lee, Seong Hoon Yoon, Jin-Yeong Yu, Hee-Jung Ban, Yong Soo Kwon, In Jae Oh, Kyu-Sik Kim, Young-Chul Kim, Sung-Chul Lim
Prevalence of chronic sputum and associated factors in Korean adults. Journal of Korean medical science 29 (6) (2014)

Young-Chul Kim.css-eqlu8i{font-size:small;padding-left:4px;} (Young Chul Kim)

Publication Activity (10 Years)

Top Topics

Top Venues

Young-Chul Kim (Young Chul Kim)